BALAXI PHARMACEUTICALS LIMITED has submitted to the Exchange, the financial results for the period ended September 30, 2025.
BALAXI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Balaxi Pharmaceuticals Limited has submitted its financial results to NSE for the quarter and half-year ended September 30, 2025. The filing is a routine regulatory disclosure required of listed companies after each quarter. No specific revenue, profit, or margin figures are mentioned in this announcement notice. Detailed financial performance would need to be reviewed from the actual results document filed with the exchange. Shareholders and analysts typically look at these filings to track quarterly revenue trends, profit after tax, and margin performance.
The submission itself is a procedural compliance event and is unlikely to move the stock on its own. Any price reaction would depend on the actual numbers in the results, particularly revenue growth, profit after tax, and margin trends compared to prior periods and street expectations.